IP Verse

Composition Containing A Yeast For Preventing Simple And/Or Recurring Cystitis - EP3979834

The patent EP3979834 was granted to Lesaffre ET Compagnie on Oct 23, 2024. The application was originally filed on May 29, 2020 under application number EP20733692A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3979834

LESAFFRE ET COMPAGNIE
Application Number
EP20733692A
Filing Date
May 29, 2020
Status
Granted And Under Opposition
Sep 19, 2024
Grant Date
Oct 23, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOCODEXJul 23, 2025ESSELINADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2009103884
DESCRIPTIONWO2014009656
INTERNATIONAL-SEARCH-REPORTWO2009103884
INTERNATIONAL-SEARCH-REPORTWO2014009656
OPPOSITIONFR2906109
OPPOSITIONWO2009103884
OPPOSITIONWO2015189337

Non-Patent Literature (NPL) Citations (16) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- MADDEN-FUENTES RAMIRO J ET AL, "Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis", CLINICAL THERAPEUTICS, EXCERPTA MEDICA, PRINCETON, NJ, US, (20150729), vol. 37, no. 9, doi:10.1016/J.CLINTHERA.2015.06.018, ISSN 0149-2918, pages 2143 - 2147, XP029267367 [X] 1-3,6-8 * the whole document * [Y] 1-3,6-11
INTERNATIONAL-SEARCH-REPORT- CAROL A. KAUFFMAN ET AL, "Candida Urinary Tract Infections-Diagnosis", CLINICAL INFECTIOUS DISEASES, US, (20110515), vol. 52, no. suppl_6, doi:10.1093/cid/cir111, ISSN 1058-4838, pages S452 - S456, XP055680368 [Y] 1-3,6-11 * abstract *
INTERNATIONAL-SEARCH-REPORT- ANUM KHAN ET AL, "Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children", JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, (20180723), vol. 8, no. 2, doi:10.1093/jpids/piy065, pages 152 - 159, XP055680219 [Y] 1-3,6-11 * voir page 156 *
OPPOSITION- Colgan, Williams, "Diagnosis and Treatment of Acute Uncomplicated Cystitis", AMERICAN FAMILY PHYSICIAN, American Academy of Family Physicians, US, US , (20111001), vol. 84, no. 7, ISSN 0002-838X, pages 771 - 776, XP093303456-
OPPOSITION- Monard André, Gérard Benoit, Louis Jacques, Alain Jardin, "Fréquence des colibacilles adhérents dans une population de pyélonéphrite aiguë et dans une population de cystite aiguë", PROGRES EN UROLOGIE, ASSOCIATION FRANCAISE D'UROLOGIE, PARIS, FR, FR , (19930801), vol. 3, no. 4, ISSN 1166-7087, pages 583 - 589, XP093303458-
OPPOSITION- Ipek Akil ; Ozge Yilmaz ; Semra Kurutepe ; Kenan Degerli ; Salih Kavukcu, "Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora", Pediatric Nephrology ; Journal of the International Pediatric Nephrology Association, Springer, Berlin, DE, Berlin, DE , (20060420), vol. 21, no. 6, doi:10.1007/s00467-006-0088-4, ISSN 1432-198X, pages 807 - 810, XP019428936
OPPOSITION- Elkhihal B.; Elhalimi M.; Ghfir B.; Mostachi A.; Lyagoubi M.; Aoufi S., "Infection urinaire àSaccharomyces cerevisiae : levure émergente ?", Journal de Mycologie Médicale, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19000101), vol. 25, no. 4, doi:10.1016/j.mycmed.2015.09.004, ISSN 1156-5233, pages 303 - 305, XP029339090
OPPOSITION- Jann K, Schmidt G, Blumenstock E, Vosbeck K, "Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity", Infection and immunity, American Society for Microbiology, US, US , (19810501), vol. 32, no. 2, doi:10.1128/iai.32.2.484-489.1981, ISSN 0019-9567, pages 484 - 489, XP093303485
OPPOSITION- Korhonen Timo K., Leffler Hakon, Edén Catharina Svanborg, "Binding Specificity of Piliated Strains of Escherichia coli and Salmonella typhimurium to Epithelial Cells, Saccharomyces cerevisiae Cells, and Erythrocytes", Infection and immunity, American Society for Microbiology, US, US , (19810501), vol. 32, no. 2, doi:10.1128/iai.32.2.796-804.1981, ISSN 0019-9567, pages 796 - 804, XP093303487
OPPOSITION- Saoud Mohamed Zaïd, Rhatous Mustapha, Mire Samira El, Lyagoubi Mohammed, Aoufi Sarra, "Saccharomyces cerevisiae, une levure de plus en plus impliquée dans les infections urinaires: à propos de 3 cas", The Pan African medical journal, African Field Epidemiology Network, Uganda, Uganda , (20200303), vol. 35, doi:10.11604/pamj.2020.35.63.18041, ISSN 1937-8688, pages 63 - 4, XP093303490
OPPOSITION- Duane Sinead, Vellinga Akke, Murphy Andrew W., Cormican Martin, Smyth Andrew, Healy Patricia, Moore Michael, Little Paul, Devane Declan, "COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults", TRIALS, BIOMED CENTRAL, LONDON, GB, GB , (20191201), vol. 20, no. 1, doi:10.1186/s13063-019-3194-x, ISSN 1745-6215, pages 106 - 6, XP093303455
OPPOSITION- Rezuqi Nada S., Younis Farah Q., "Inhibition activity of Saccharomyces boulardii and Lactobacillus acidophilus against pathogenic E.coli isolates from Recurrent Urinary Tract Infection in women In Vitro", Baghdad Science Journal, College of Science for Women, University of Baghdad, Iraq, (20140101), vol. 11, no. 1, doi:10.21123/bsj.2014.11.1.22-32, ISSN 2078-8665, pages 22 - 32, XP093303478
OPPOSITION- Ruba Kello, "ORAL VIAL WITH PLUNGER AND TEAR OFF CAP (VPTC) IS AN ALTERNATIVE DOSAGE FORM FOR DIETARY SUPPLEMENTS INTRODUCTION", Jornal of Critical Reviews, (20160920), doi:10.22159/jcr.2016v3i4.14417, XP055411440
OPPOSITION- Anonymous, "Scientific Opinion on the substantiation of a health claim related to Saccharomyces cerevisiae var. boulardii CNCM I‐3799 and reducing gastro‐intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006", EFSA journal, European Food Safety Authority, Parma, Italy, Parma, Italy, (20120701), vol. 10, no. 7, doi:10.2903/j.efsa.2012.2801, ISSN 1831-4732, pages 1 - 9, XP093303495
OPPOSITION- Quattrone Carmelo, Manfredi Celeste, Napolitano Luigi, Ferraro Angelo, Distefano Concetta, Di Girolamo Antonio, Sciorio Carmine, Imperatore Vittorio, Bottone Francesco, La Rocca Roberto, Arcaniolo Davide, De Sio Marco, Spirito Lorenzo, "D-Mannose Plus Saccharomyces boulardii to Prevent Urinary Tract Infections and Discomfort after Cystoscopy: A Single-Center Prospective Randomized Pilot Study", Medicina, Lithuania, Lithuania , (20230601), vol. 59, no. 6, doi:10.3390/medicina59061165, ISSN 1648-9144, pages 1165 - 8, XP093303482
OPPOSITION- Lee Jaewoong, Kim Hyunjung, Lee Hae Kyung, Park Yeon-Joon, "A Case Report of Saccharomyces cerevisiae Fungemia in a Premature Infant Following Probiotic Treatment", Annals of Clinical Microbiology, (20200901), vol. 23, no. 3, doi:10.5145/ACM.2020.23.3.5, ISSN 2288-0585, pages 155 - 158, XP093303480

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents